E-Signature Compliance Checklist for Regulated Industries [2026]

Key Takeaways: Healthcare: HIPAA E-Signature Requirements · Financial Services: SEC/FINRA/SOX Compliance · Life Sciences: FDA 21 CFR Part 11 · Government: FedRAMP & NIST Requirements

Regulated industries face additional e-signature requirements beyond basic ESIGN/UETA compliance. Healthcare organizations must meet HIPAA standards, financial firms must satisfy SEC/FINRA rules, and life sciences companies must comply with FDA 21 CFR Part 11.

This checklist covers the specific requirements for each industry, so you can adopt e-signatures with confidence.

Healthcare: HIPAA E-Signature Requirements

HIPAA doesn't explicitly address electronic signatures, but the Security Rule and Privacy Rule create requirements that affect how e-signatures must be implemented:

Checklist:

• Access controls — only authorized individuals can sign
• Audit trails — complete logging of who signed what, when
• Integrity controls — tamper-evident seals on signed documents
• Person/entity authentication — verify signer identity
• Transmission security — encrypt documents in transit (TLS 1.2+)
• BAA (Business Associate Agreement) — your e-signature vendor must sign a BAA
• Minimum necessary — limit access to PHI in signed documents
• Data retention — maintain signed records per state and federal requirements

ZiaSign is HIPAA-ready and will execute a BAA with healthcare customers.

Financial Services: SEC/FINRA/SOX Compliance

Financial institutions face requirements from multiple regulators:

SEC Rule 17a-4 (record retention):

• Store electronic records in non-rewriteable, non-erasable format
• Retain records for specified periods (3-6 years depending on type)
• Provide records to regulators upon request

FINRA Rules:

• Books and records must be complete and accurate
• Customer signatures must demonstrate clear consent
• Supervisory review procedures for electronically signed documents

SOX (Sarbanes-Oxley):

• Internal controls over financial document signing
• Audit trail for all financial authorizations
• Retention of signed financial records per SOX requirements

Life Sciences: FDA 21 CFR Part 11

The FDA's 21 CFR Part 11 is one of the most stringent e-signature regulations:

Requirements:

• Electronic signatures must be unique to one individual
• Signatures cannot be reused or reassigned
• Electronic signatures must include printed name, date/time, and meaning (approval, review, etc.)
• Systems must use operational checks to enforce signing sequences
• Authority checks must ensure only authorized individuals sign
• Continuous session monitoring during signing
• Digital signatures must employ cryptographic techniques
• Organization must certify to FDA that electronic signatures are equivalent to handwritten

ZiaSign supports all Part 11 requirements through its compliance module.

Government: FedRAMP & NIST Requirements

Government agencies and their contractors must meet federal IT security standards:

• FedRAMP authorization (or equivalent) for cloud-based e-signature platforms
• NIST 800-63 digital identity guidelines compliance
• FIPS 140-2/140-3 validated cryptographic modules
• Continuous monitoring and reporting
• Federal Records Act compliance for record retention
• Accessibility (Section 508 WCAG 2.1 AA)
• Data sovereignty — US-based data storage and processing

This article is part of ZiaSign's comprehensive resource library. Explore more guides at ziasign.com/blogs, or try our 119 free PDF tools.